NCT00004104 2016-03-31
Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma
NYU Langone Health
Phase 2 Completed
Clinical Trials
4 trialsNCT00128583 2013-12-19
Vaccine Therapy in Treating Patients With Malignant Melanoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00052130 2005-06-24
Vaccine Therapy for Patients With Stage III Melanoma
CancerVax Corporation
Phase 3 Unknown
NCT00052156 2005-06-24
Vaccine Therapy for Patients With Stage IV Melanoma
CancerVax Corporation
Phase 3 Unknown